Cite
HARVARD Citation
Aghaei, A. et al. (n.d.). Comparison of treatment efficacy 1 and 2 years after thyroid remnant ablation with 1110 versus 5550 MBq of iodine-131 in patients with intermediate-risk differentiated thyroid cancer. Nuclear medicine communications. 38 (11), p. . [Online].